KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Opko Health (OPK) EBITDA Margin: 2010-2025

Historic EBITDA Margin for Opko Health (OPK) over the last 16 years, with Sep 2025 value amounting to 31.68%.

  • Opko Health's EBITDA Margin fell 2730.00% to 31.68% in Q3 2025 from the same period last year, while for Sep 2025 it was -17.48%, marking a year-over-year increase of 1597.00%. This contributed to the annual value of -21.32% for FY2024, which is 314.00% down from last year.
  • Opko Health's EBITDA Margin amounted to 31.68% in Q3 2025, which was up 182.83% from -38.25% recorded in Q2 2025.
  • Opko Health's 5-year EBITDA Margin high stood at 3,782.60% for Q3 2021, and its period low was -1,223.76% during Q1 2023.
  • Its 3-year average for EBITDA Margin is -125.50%, with a median of -36.06% in 2023.
  • As far as peak fluctuations go, Opko Health's EBITDA Margin spiked by 377,747bps in 2021, and later tumbled by 383,146bps in 2022.
  • Opko Health's EBITDA Margin (Quarterly) stood at -15.72% in 2021, then crashed by 1,410bps to -29.82% in 2022, then slumped by 814bps to -37.96% in 2023, then skyrocketed by 1,991bps to -18.05% in 2024, then slumped by 2,730bps to 31.68% in 2025.
  • Its EBITDA Margin stands at 31.68% for Q3 2025, versus -38.25% for Q2 2025 and -44.79% for Q1 2025.